Xultophy Injection
Marketer
Novo Nordisk India Pvt Ltd
Salt Composition
Liraglutide (3.6mg/1ml) + Insulin Degludec (100IU)
Overview Xultophy Injection
Xultophy is a dual-action injectable medication employed in managing type 2 diabetes. Its use is typically reserved for patients whose blood glucose remains inadequately controlled despite other treatments. Optimal results are achieved when combined with a healthy diet and regular physical activity. Administer Xultophy precisely as directed by your physician, following their instructions for subcutaneous injection. Consistent adherence to the prescribed dosage is crucial for maximum therapeutic benefit; discontinuation may lead to dangerously elevated blood sugar and potentially severe complications. This medication forms part of a comprehensive diabetes management plan encompassing dietary modifications, exercise, and weight management, all under your doctor's guidance. Strictly adhere to your doctor's instructions. Potential side effects include nasal stuffiness, pharyngitis, headache, upper respiratory infections, nausea, elevated blood lipase, and diarrhea. Injection site reactions such as pain, swelling, or erythema may also occur. Report any persistent or worsening side effects to your healthcare provider. Prior to commencing treatment, disclose any pre-existing kidney, liver, or cardiac conditions. Pregnant or lactating individuals should seek medical counsel before initiating Xultophy therapy. Your doctor will assess your renal function prior to treatment. Limit alcohol consumption while using Xultophy to minimize the risk of adverse events.
Primary Ingredients of Xultophy Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Xultophy Injection
Managing type 2 diabetes
Major Benefits of Xultophy Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Xultophy Injection:
- Headache
- Nausea
- Diarrhea
- Increased lipase in the blood
- Hypoglycemia (low blood glucose level)
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Vomiting
- Decreased appetite
- Upper respiratory tract infection
- Injection site bruising
How to use Xultophy Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Xultophy Injection works:
Xultophy is an injectable combination therapy containing liraglutide and insulin degludec, two antidiabetic agents. Liraglutide enhances insulin production in response to food intake and reduces hepatic glucose output. Insulin degludec mimics the action of endogenous insulin, promoting glucose uptake by muscle and adipose tissue while suppressing hepatic glucose release. This dual mechanism delivers comprehensive, 24-hour glycemic management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Xultophy Injection with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Xultophy Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Xultophy Injection use while breastfeeding is currently unavailable. Seek your physician's advice.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Xultophy Injection. Dosage modification of Xultophy Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should use Xultophy Injection judiciously. Dosage modification of Xultophy Injection might be necessary. Physician consultation is advised.
What if you forget to take Xultophy Injection :
NA
Facts to Know About Xultophy Injection
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Diabetes Medication |